Cargando…
The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304153/ https://www.ncbi.nlm.nih.gov/pubmed/35963831 http://dx.doi.org/10.1016/j.pulmoe.2022.07.003 |
| _version_ | 1784752037524668416 |
|---|---|
| author | Giraudo, C. Guarnieri, G. Molena, B. Caminati, M. Stramare, R. Vianello, A. |
| author_facet | Giraudo, C. Guarnieri, G. Molena, B. Caminati, M. Stramare, R. Vianello, A. |
| author_sort | Giraudo, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9304153 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93041532022-07-22 The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure Giraudo, C. Guarnieri, G. Molena, B. Caminati, M. Stramare, R. Vianello, A. Pulmonology Letter to the Editor Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. 2022-07-22 /pmc/articles/PMC9304153/ /pubmed/35963831 http://dx.doi.org/10.1016/j.pulmoe.2022.07.003 Text en © 2022 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Giraudo, C. Guarnieri, G. Molena, B. Caminati, M. Stramare, R. Vianello, A. The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure |
| title | The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure |
| title_full | The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure |
| title_fullStr | The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure |
| title_full_unstemmed | The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure |
| title_short | The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure |
| title_sort | lung-protective effect of prior mrna vaccination on breakthrough covid-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304153/ https://www.ncbi.nlm.nih.gov/pubmed/35963831 http://dx.doi.org/10.1016/j.pulmoe.2022.07.003 |
| work_keys_str_mv | AT giraudoc thelungprotectiveeffectofpriormrnavaccinationonbreakthroughcovid19patientsreceivinghighflownasaloxygenforhypoxemicacuterespiratoryfailure AT guarnierig thelungprotectiveeffectofpriormrnavaccinationonbreakthroughcovid19patientsreceivinghighflownasaloxygenforhypoxemicacuterespiratoryfailure AT molenab thelungprotectiveeffectofpriormrnavaccinationonbreakthroughcovid19patientsreceivinghighflownasaloxygenforhypoxemicacuterespiratoryfailure AT caminatim thelungprotectiveeffectofpriormrnavaccinationonbreakthroughcovid19patientsreceivinghighflownasaloxygenforhypoxemicacuterespiratoryfailure AT stramarer thelungprotectiveeffectofpriormrnavaccinationonbreakthroughcovid19patientsreceivinghighflownasaloxygenforhypoxemicacuterespiratoryfailure AT vianelloa thelungprotectiveeffectofpriormrnavaccinationonbreakthroughcovid19patientsreceivinghighflownasaloxygenforhypoxemicacuterespiratoryfailure AT giraudoc lungprotectiveeffectofpriormrnavaccinationonbreakthroughcovid19patientsreceivinghighflownasaloxygenforhypoxemicacuterespiratoryfailure AT guarnierig lungprotectiveeffectofpriormrnavaccinationonbreakthroughcovid19patientsreceivinghighflownasaloxygenforhypoxemicacuterespiratoryfailure AT molenab lungprotectiveeffectofpriormrnavaccinationonbreakthroughcovid19patientsreceivinghighflownasaloxygenforhypoxemicacuterespiratoryfailure AT caminatim lungprotectiveeffectofpriormrnavaccinationonbreakthroughcovid19patientsreceivinghighflownasaloxygenforhypoxemicacuterespiratoryfailure AT stramarer lungprotectiveeffectofpriormrnavaccinationonbreakthroughcovid19patientsreceivinghighflownasaloxygenforhypoxemicacuterespiratoryfailure AT vianelloa lungprotectiveeffectofpriormrnavaccinationonbreakthroughcovid19patientsreceivinghighflownasaloxygenforhypoxemicacuterespiratoryfailure |